For years, the adoption of red light therapy was stifled by costs exceeding $1,000 for professional-grade setups. By utilizing a direct-to-consumer model, Comfytemp intends to bridge the gap between clinical-grade performance and household budgets. The new device features a dual-wavelength design, emitting 660nm red light and 850nm near-infrared light, which are frequently cited in research for their role in supporting mitochondrial activity and cellular energy production.
In section Releases
Comfytemp Enters Home Wellness Market with 55W Red Light Therapy Panel
With the global light therapy market projected to hit $1.44 billion by 2030, Comfytemp is challenging the dominance of high-end clinical equipment. The company launched a 55W high-irradiance red light therapy panel today, aiming to bring photobiomodulation technology into residential spaces at a significantly lower price point than traditional professional systems.
Beyond basic functionality, the 55W panel emphasizes hardware stability and user control. The device includes a floor-standing structure to ensure consistent irradiance during sessions, alongside app-based settings that allow users to customize their treatment parameters. As consumer interest in biohacking and proactive recovery continues to rise, the shift toward accessible, high-performance hardware signals a move away from the premium-only positioning that historically defined the sector.
Comments (0)
No comments yet. Be the first!